CLH
Clean Harbors, Inc.
CLH's fundamentals are strong: earnings per share grew 38% and revenue grew 10%. At 30x earnings, it's trading in line with its usual 31x. Analysts expect earnings growth, though they disagree widely on how much.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CLH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
CLH's revenue, profitability, cash flow and balance sheet are all currently healthy.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CLH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 22x | $217 | -26% |
| Current | 30x | $294 | — |
| Forward | 30x | $294 | — |
| Fair | 31x | $307 | +4.3% |
| Expensive | 37x | $366 | +24% |
Historical ranges are pointers, not guarantees.
CLH's PE is in its fair range at 29.5x. On analysts' estimates for next year's earnings, today's price would be 30.2x.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CLH Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CLH, but weaker profitability. However, they disagree widely on these estimates.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CLH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.74 | -2.3% |
| Q3 2026 | $9.96 | +38% |
| Q2 2026 | $8.24 | +16% |
| Q1 2026 | $7.38 | +2.2% |
| Q4 2025 | $7.28 | -1.9% |
| Q3 2025 | $7.21 | -6.1% |
| Q2 2025 | $7.12 | -1.7% |
| Q1 2025 | $7.22 | +4.5% |
| Q4 2024 | $7.42 | +6.8% |
CLH has the stronger earnings trend. Trailing diluted EPS is up 38% for CLH versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CLH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +21% |
| Q2 2026 | $1.7B | +12% |
| Q1 2026 | $1.5B | +1.9% |
| Q4 2025 | $1.5B | +4.8% |
| Q3 2025 | $1.5B | +1.3% |
| Q2 2025 | $1.5B | -0.2% |
| Q1 2025 | $1.4B | +4% |
| Q4 2024 | $1.4B | +6.9% |
CLH's revenue has grown year over year for five quarters in a row: $1.9B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +4.6 points |
| Q2 2026 | 16% | +1.9 points |
| Q1 2026 | 8.2% | +0.4 points |
| Q4 2025 | 11% | +1 points |
| Q3 2025 | 12% | -0.1 points |
| Q2 2025 | 14% | -0.3 points |
| Q1 2025 | 7.8% | -1.3 points |
| Q4 2024 | 9.6% | -1.4 points |
CLH has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CLH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CLH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $246.4M | +19% |
| Q2 2026 | $113M | -4.3% |
| Q1 2026 | -$92.1M | +$24.9M |
| Q4 2025 | $233.3M | -3.4% |
| Q3 2025 | $207.5M | +46% |
| Q2 2025 | $118M | +46% |
| Q1 2025 | -$117.1M | +$2.3M |
| Q4 2024 | $241.5M | +43% |
CLH has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
CLH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -64K shares |
| 1 year | -1.5% | -816K shares |
| 3 years | -2.8% | -1.5M shares |
| 5 years | -3.3% | -1.8M shares |
| Available history | -5.8% | -3.2M shares |
CLH has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $27.1M |
| Q1 2026 | $25M |
| Q4 2025 | $133M |
| Q3 2025 | $50M |
| Q2 2025 | $12M |
| Q1 2025 | $55M |
| Q4 2024 | $25M |
CLH spent $210M buying back its own shares over the past year, up 48% from the year before.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
CLH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 2.0x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.8x | Healthy |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.0x | Healthy |
CLH's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CLH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 18.5 | Oversold |
CLH's weekly RSI is 46 (neutral) and its Stochastic is 19 (oversold).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CLH PE vs Industrials Sector
| Metric | CLH | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 24x | 23% above |
| PE % | 41 | 58 | 17 pts below |
CLH is trading at 30x earnings, a 23% premium to the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CLH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $308.4 | 4.7% below |
| 20 week MA | $310.1 | 5.2% below |
| 50 week MA | $290.6 | 1.1% above |
| 100 week MA | $257.9 | 14% above |
| 200 week MA | $222.0 | 32% above |
CLH has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CLH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86.2 | $75.3 | -13% |
| 2021 | $75.3 | $95.6 | +27% |
| 2022 | $95.6 | $114.8 | +20% |
| 2023 | $114.8 | $174.5 | +52% |
| 2024 | $174.5 | $229.6 | +32% |
| 2025 | $229.6 | $240.8 | +4.9% |
| 2026 YTD | $240.8 | $293.8 | +22% |
CLH has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.